Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:1181-1189
Published online before print September 25, 2008, doi: 10.1161/CIRCRESAHA.108.185645
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/10/1181    most recent
CIRCRESAHA.108.185645v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moura, R.
Right arrow Articles by Hoylaerts, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moura, R.
Right arrow Articles by Hoylaerts, M. F.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Smooth muscle proliferation and differentiation
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article
(Circulation Research. 2008;103:1181.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE–/– Mice

Rute Moura, Marc Tjwa, Petra Vandervoort, Soetkin Van kerckhoven, Paul Holvoet, Marc F. Hoylaerts

From the Center for Molecular and Vascular Biology (R.M., P.V., S.V.k., M.F.H.); Center for Transgene Technology and Gene Therapy (M.T.); and Atherosclerosis and Metabolism Unit (P.H.), Department of Cardiovascular Diseases, University of Leuven, Belgium.

Correspondence to Marc Hoylaerts, PhD, Center for Molecular and Vascular Biology, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail Marc.Hoylaerts{at}med.kuleuven.be

Thrombospondin (TSP)1 is implicated in various inflammatory processes, but its role in atherosclerotic plaque formation and progression is unclear. Therefore, the development of atherosclerosis was compared in ApoE–/– and Tsp1–/–ApoE–/– mice kept on a normocholesterolemic diet. At 6 months, morphometric analysis of the aortic root of both mouse genotypes showed comparable lesion areas. Even when plaque burden increased {approx}5-fold in ApoE–/– and 10-fold in Tsp1–/–ApoE–/– mice, during the subsequent 3 months, total plaque areas were comparable at 9 months. In contrast, plaque composition differed substantially between genotypes: smooth muscle cell areas, mostly located in the fibrous cap of ApoE–/– plaques, both at 6 and 9 months, were 3-fold smaller in Tsp1–/–ApoE–/– plaques, which, in addition, were also more fibrotic. Moreover, inflammation by macrophages was twice as high in Tsp1–/–ApoE–/– plaques. This correlated with a 30-fold elevated incidence of elastic lamina degradation, with matrix metalloproteinase-9 accumulation, underneath plaques and manifestation of ectasia, exclusively in Tsp1–/–ApoE–/– mice. At 9 months, the necrotic core was 1.4-fold larger and 4-fold higher numbers of undigested disintegrated apoptotic cells were found in Tsp1–/–ApoE–/– plaques. Phagocytosis of platelets by cultured Tsp1–/– macrophages revealed the instrumental role of TSP1 in phagocytosis, corroborating the defective intraplaque phagocytosis of apoptotic cells. Hence, the altered smooth muscle cell phenotype in Tsp1–/–ApoE–/– mice has limited quantitative impact on atherosclerosis, but defective TSP1-mediated phagocytosis enhanced plaque necrotic core formation, accelerating inflammation and macrophage-induced elastin degradation by metalloproteinases, speeding up plaque maturation and vessel wall degeneration.


Key Words: atherosclerosis • matricellular proteins • transgenic mice • vascular inflammation


Related Article:

Counterbalancing Forces: What Is Thrombospondin-1 Doing in Atherosclerotic Lesions?
Olga I. Stenina and Edward F. Plow
Circ. Res. 2008 103: 1053-1055. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
B. K. Tan, R. Adya, J. Chen, S. Farhatullah, D. Heutling, D. Mitchell, H. Lehnert, and H. S. Randeva
Metformin decreases angiogenesis via NF-{kappa}B and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1
Cardiovasc Res, August 1, 2009; 83(3): 566 - 574.
[Abstract] [Full Text] [PDF]